Background: Surgery for patients with malignant obstructive jaundice carries high morbidity and mortality rates. Preoperative biliary drainage (PBD) has been used in an attempt to improve the outcome in these patients. Aim: To review the evidence in the literature on whether PBD improves postoperative morbidity and mortality in obstructive jaundice patients. Method: Using Medline a literature search was performed for papers published in English from January 1980 to October 2000, using the text words ‘obstructive jaundice’, ‘preoperative’, ‘drainage’ and ‘stent’. All retrieved papers which reported experimental or clinical observations relevant to the study aim were carefully analysed and the findings are summarised in this review. Results and Conclusion: There is no evidence in the literature to support the view that routine PBD improves postoperative morbidity and mortality in patients with obstructive jaundice undergoing resection. PBD has its own complications that cancel out its benefits. However, PBD could be beneficial in patients presenting with sepsis, coagulation abnormalities or malnutrition.

Keywords:
Jaundice, Obstruction, Preoperative drainage, Stent
1.
Povoski SP, Karpeh MS, Conlon KC, Blumgart LH, Brennan MF: Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy. Ann Surg 1999;230:131–142.
2.
Lai ECS, Chu KM, Lo CY, et al: Surgery for malignant obstructive jaundice: Analysis of mortality. Surgery 1992;112:891–896.
3.
Parks RW, Clents WDB, Smye MG, Pope C, Rowlands BJ, Diamond T: Intestinal barrier dysfunction in clinical and experimental obstructive jaundice and its reversal by internal biliary drainage. Br J Surg 1996;83:1345–1349.
4.
Clements WDB, McCaigue M, Erwin P, Halliday I, Rolands BJ: Biliary decompression promotes Kupffer cell recovery in obstructive jaundice. Gut 1996;38:925–931.
5.
Hirazawa K, Hazama S, Oka M: Depressed cytotoxic activity of hepatic nonparenchymal cells in rats with obstructive jaundice. Surgery 1999;126:900–907.
6.
Martinez-Rodenas F, Pereira JA, Jimenez W, Gubern JM, Stiges-Serra A: Circulating bile is the main factor responsible for atrial natriuretic peptide release in experimental obstructive jaundice. Br J Surg 1998;85:480–484.
7.
Gallardo JM, Padillo J, Martin-Malo A, Mino G, Pera C, Stiges-Serra A: Increased plasma levels of atrial natriuretic peptide and endocrine markers of volume depletion in patients with obstructive jaundice. Br J Surg 1998;85:28–31.
8.
Gouma DJ, Coelho JCU, Schlegel JF, Li YF, Moody FG: The effect of postoperative internal and external biliary drainage on mortality of jaundiced rats. Arch Surg 1987;122:371–374.
9.
Gouma DJ, Coelho JCU, Schlegel JF, Li YF, Moody FG: Endotoxaemia after relief of biliary obstruction by internal and external drainage in rats. Am J Surg 1986;151:476–479.
10.
Greve JW, Maessen JG, Tiebosch T, Buurman WA, Gouma DJ: Prevention of postoperative complications in jaundiced rats. Internal biliary drainage versus oral lactulose. Ann Surg 1990;212:221–227.
11.
Megison SM, Dunn CW, Hoton JW, Chao H: Effects of relief of biliary obstruction on mononuclear phagocyte system function and cell mediated immunity. Br J Surg 1990;77:1229–1232.
12.
Saiki S, Chijiiwa K, Komura M, Yamaguchi K, Kuroki S, Tanaka M: Preoperative internal biliary drainage is superior to external biliary drainage in liver regeneration and function after hepatectomy in obstructive jaundice in rats. Ann Surg 1999;230:655–662.
13.
Karsten T, Davids P, van Gulik TM, Bosma A, Tygat GN, Klopper PJ, van der Heyde MN: Effects of biliary endoprotheses on the extrahepatic duct in relation to subsequent operation of the biliary tract. J Am Coll Surg 1994;178:343–352.
14.
Nakayama T, Ikeda A, Okuda K: Percutaneous transhepatic drainage of the biliary tract. Gastroenterology 1978;74:554–559.
15.
Hatfield ARW, Terblanche J, Fataar S, et al: Preoperative external biliary drainage in obstructive jaundice: A prospective controlled clinical trial. Lancet 1982;ii:896–899.
16.
McPherson GAD, Benjamin IS, Hodgson HJF, Bowley NB, Allison DJ, Blumgart LH: Preoperative percutaneous transhepatic biliary drainage: The results of controlled trial. Br J Surg 1984;71:371–375.
17.
Pitt HA, Gomes AS, Lois JF, et al: Does pre- operative percutaneous biliary drainage reduce operative risk or increase hospital cost? Ann Surg 1985;201:545–553.
18.
Denning DA, Ellison EC, Carey LC: Preoperative percutaneous transhepatic biliary decompression lowers operative morbidity in patients with obstructive jaundice. Am J Surg 1981;141:61–65.
19.
Carrasco CH, Zoirnoza J, Bechtel WJ: Malignant biliary obstruction: Complications of percutaneous biliary drainage. Radiology 1984;152:343–346.
20.
Joseph PK, Bizer LS, Spraygregen SS: Percutaneous transhepatic biliary drainage: Results and complications in 81 patients. JAMA 1986;255:2763–2767.
21.
Gouma DJ, Moody FG: Preoperative percutaneous biliary drainage: Use or abuse. Surg Gastroenterol 1984;3:74–80.
22.
Kawarada Y, Higashiguchi T, Yokoi H, Vaidya P, Mizumoto R: Preoperative biliary drainage in obstructive jaundice. Hepatogastroenterology 1995;42:300–307.
23.
Chapman WC, Sharp KW, Weaver F, Sawyer JL: Tumour seeding from percutaneous biliary catheters. Ann Surg 1989;209:708–711.
24.
Hochwald SN, Burke EC, Jarnagin WR, Fong Y, Blumgart LH: Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg 1999;134:261–266.
25.
Lai CS, Mok FPT, Fan ST, Lo CM, Chu KM, Liu CL, Wong J: Pre-operative endoscopic drainage for malignant obstructive jaundice. Br J Surg 1994;81:1195–1198.
26.
Klinkenbijil JHG, Jeekel J, Schmitz PIM, Rombout PAR, Nix GAJJ, Bruining HA, van Blankenstein M: Carcinoma of the pancreas and periampullary region: Palliation versus cure. Br J Surg 1993;80:1575–1578.
27.
Trede M, Schwall G: The complications of pancreatectomy. Ann Surg 1988;207:39–47.
28.
Heslin MJ, Brooks AD, Hochwald SN, Harrison LE, Blumgart LH, Brennan MF: A pre-operative biliary stent is associated with increased complications after pancreatoduodenectomy. Arch Surg 1998;133:149–154.
29.
Nimura Y, Hayakawa N, Kamiya J: Combined portal vein and liver resection for carcinoma of the biliary tract. Br J Surg 1991;78:727–731.
30.
Miyagawa S, Makuuchi M, Kawasaki S: Outcome of extended right hepatectomy after biliary drainage in hilar bile duct cancer. Arch Surg 1995;130:759–761.
31.
Cherqui D, Benoist S, Malassagne B, Humeres R, Rodriguez V, Fagniez PL: Major liver resection for carcinoma in jaundiced patients without preoperative biliary drainage. Arch Surg 2000;135:302–308.
32.
Nagino M, Nimura Y, Hayakawa N: Logistic regression and discriminate analysis of hepatic failure after liver resection for carcinoma of the biliary tract. World J Surg 1993;17:250–255.
33.
Tracy TF Jr, Bailry PV, Gorke ME, Stelo-Avila C, Weber TR: Cholestasis without cirrhosis alters regulatory liver gene expression and inhibits hepatic regeneration. Surgery 1991;110:176–183.
34.
Pellegrini CA, Allegra P, Bongard F, Way LW: Risk of biliary surgery in patients with hyperbilirubinaemia. Am J Surg 1987;154:111–116.
35.
Armstrong CP, Dixon JM, Taylor TV, Davies GC: Surgical experience of deeply jaundiced patients with bile duct obstruction. Br J Surg 1984;71:234–238.
36.
Koyama K, Takagi Y, Ito K, et al: Experimental and clinical studies on the effect of biliary drainage in obstructive jaundice. Am J Surg 1981;142:293–299.
37.
Lillemoe KD: Preoperative biliary drainage and surgical outcome (editorial). Ann Surg 1999;230:143–144.
38.
Smith RC, Pooley M, George CRP, Faithful GR: Preoperative percutaneous transhepatic internal drainage in obstructive jaundice: A randomised, controlled trial examining renal function. Surgery 1985;97:641–647.
39.
Ceuterick M, Gelin M, Rickaert F, Van de Stadt J, Deviere J, Cremer M, Lambilliotte JP: Pancreaticoduodenal resection for pancreatic or periampullary tumours – A ten-year experience. Hepatogastroenterology 1989;36:467–473.
40.
Bakkevold KE, Kambestad B: Morbidity and mortality after radical and palliative pancreatic cancer surgery. Ann Surg 1993;217:356–368.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.